Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 15/20 | 0.54 |
| ▸ | MTNR1B | P49286 | 15/20 | 0.54 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.54 |
| ▸ | HTR2B | P41595 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.49 |
| ▸ | NQO2 | P16083 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.49 |
| ▸ | BLM | P54132 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | SPR | P35270 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25295069 | 0.86 | MTNR1A (0.61) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 | |
| SCHEMBL29437233 | 0.86 | MTNR1A (0.61) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 | |
| SCHEMBL25383295 | 0.84 | MTNR1A (0.55) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 | |
| SCHEMBL25381610 | 0.80 | MTNR1A (0.57) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 | |
| SCHEMBL26202196 | 0.78 | MTNR1A (0.69) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 | |
| SCHEMBL26202014 | 0.76 | MTNR1A (0.58) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 | |
| SCHEMBL26202204 | 0.76 | MTNR1A (0.56) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 | |
| SCHEMBL25302584 | 0.75 | MTNR1A (0.61) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 | |
| SCHEMBL25381235 | 0.75 | HTR2B (0.65) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 | |
| SCHEMBL30505588 | 0.75 | HTR2B (0.77) | MTNR1AMTNR1BNOTUMHTR2BCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270768-A1 | MULTI-SUBSTITUENT PSILOCYBIN DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-08-31 | — | — | US | disclosed |
| US-20230270768-A1 | MULTI-SUBSTITUENT PSILOCYBIN DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270768-A1 | MULTI-SUBSTITUENT PSILOCYBIN DERIVATIVES AND METHODS OF USING | CNR2, CNR1, HTR1B | MTNR1A 927/4885MTNR1B 122/4885NOTUM 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.